Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 69 clinical trials
The BeLimumab Antiphospholipid Syndrome Trial (BLAST) (BLAST)

positivity and clinical features attributable to aPL that are resistant to warfarin and/or heparin.

glycoprotein
anticardiolipin antibody
warfarin
anticoagulant
lupus
  • 6 views
  • 05 Jun, 2022
  • 1 location
Low INR to Minimize Bleeding With Mechanical Valves Trial (LIMIT)

valve who require lifelong warfarin (Coumadin) treatment.

  • 0 views
  • 17 Feb, 2022
  • 4 locations
Rivaroxaban in Left Ventricular Thrombus

efficacy. However, sample size of the study (n=79; 39 in Rivaroxaban and 40 Warfarin) was not sufficiently high enough to conclude efficacy of Rivaroxaban in these patients. Therefore, this open label RCT

infarct
myocardial infarction
acute coronary syndrome
  • 0 views
  • 28 Jul, 2021
  • 1 location
Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation (ERSAF)

> Rivaroxaban, a direct coagulation factor Ⅹa inhibitor, blocks the formation of the clot. ROCKET-AF study has shown that the efficacy of rivaroxaban is not inferior to that of warfarin in AF patients on stroke

heart failure
diabetes
stroke
warfarin
coagulation factor
  • 13 views
  • 11 Mar, 2022
  • 1 location
Study of Apixaban in Patients Receiving Hemodiafiltration

strokes by 5. Anticoagulation with warfarin significantly reduces the incidence of ischemic strokes in the general population, has a long half-life, and a narrow therapeutic index that requires periodic

anticoagulation therapy
stroke
warfarin
apixaban
dabigatran
  • 0 views
  • 19 Jul, 2021
  • 1 location
Coordination of Oral Anticoagulant Care at Hospital Discharge (COACHeD)

Oral anticoagulants (OACs - warfarin, dabigatran, rivaroxaban, apixaban and edoxaban) are the very top cause of serious drug-related harm. More than 7 million prescriptions are dispensed

  • 0 views
  • 12 Mar, 2022
  • 1 location
Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

The purpose of this study is to evaluate the efficacy and safety of new oral anticoagulants and vitamin K antagonists for the anticoagulation for the implantation of vena cava filters in patients with deep venous thrombosis.

anticoagulation therapy
vitamin k
warfarin
anticoagulants
rivaroxaban
  • 69 views
  • 20 Sep, 2021
  • 7 locations
Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion

Comparison among three different antithrombotic strategies after percutaneous LAA occlusion with a Watchman FLX LAAC device.

left atrial appendage occlusion
  • 0 views
  • 25 Jan, 2021
  • 1 location
Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study

The purpose of this study is to evaluate the efficacy and safety of rivaroxaban for the prevention of deep vein thrombosis in patients with left iliac vein compression treated with stent implantation.

  • 0 views
  • 28 Jan, 2021
  • 9 locations
Impact of Steady State Cobicistat and Darunavir/Cobicistat on the Pharmacokinetics and Pharmacodynamic of Oral Anticoagulants (Rivaroxaban, Apixaban) in Health Volunteers

Background Rivaroxaban and apixaban are blood thinners. People with HIV may need to take them to treat or prevent blood clots. The anti-HIV drug darunavir (DRV) can increase the amount of these blood thinners in the body. This can cause bleeding or other health problems. The drug cobicistat (COBI) is …

fasting
blood test
Accepts healthy volunteers
body mass index
  • 6 views
  • 19 Jun, 2022
  • 1 location